Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluating first-line bevacizumab, carboplatin, and paclitaxel in stage III-IV ovarian, primary peritoneal, and fallopian tu…
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 [Phase 1, Phase 2]
Phase 1/2 trial evaluating NY-ESO-1–targeted T-cell therapy with or without decitabine in patients with NY-ESO-1–expressing advanced cancers…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors [Phase 2]
Phase 2 trial evaluating autologous peripheral blood stem cell transplant for germ cell tumors (childhood germ cell tumor and ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer [Phase 3]
Phase 3 trial comparing primary debulking surgery to neoadjuvant chemotherapy for stage IV ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 trial investigating dasatinib combined with ifosfamide, carboplatin, and etoposide in young patients with metastatic or recu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab and bevacizumab with chemotherapy followed by pembrolizumab, bevacizumab, and olaparib in recurrent o…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy [Phase 3]
Phase 3 trial evaluating Fluzoparib with or without Apatinib versus placebo for maintenance in advanced ovarian cancer after response to fir…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies [Phase 2]
Phase 2 clinical trial evaluating ScTILs (genetically modified tumor infiltrating lymphocytes) for cervical and ovarian cancers (and maligna…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin [Phase 2]
Phase 2 trial update evaluating intraperitoneal paclitaxel and carboplatin in women with carcinoma of Mullerian origin starting with ovarian…
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status [Phase 2]
Phase 2 trial update on olaparib tablets for ovarian cancer with varying homologous recombination deficiency (HRD) status shows completed re…
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers [Phase 1, Phase 2]
A Phase 1/2 trial update reports completed results for combining topotecan with the ATR inhibitor berzosertib (VX-970/M6620) in small cell c…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Effect of Albumin-bound Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian, Fallopian Tube or Peritoneal Cancer: A Phase 2 Single Center Clinical Trial [Phase 2]
Phase 2 trial comparing albumin-bound paclitaxel plus carboplatin vs paclitaxel plus carboplatin in neoadjuvant setting for advanced ovarian…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors [Phase 2]
Phase 2 trial exploring DPX-Survivac with low-dose cyclophosphamide and pembrolizumab in selected advanced solid tumors; currently active/no…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Tranexamic Acid in Surgery of Advanced Ovarian Cancer [Phase 4]
Phase 4 clinical trial update for tranexamic acid in surgery for advanced ovarian cancer; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers [Phase 1]
Phase 1 trial assessing cabiralizumab with nivolumab in selected advanced cancers has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer [Phase 2]
Phase 2 clinical trial evaluating bupropion hydrochloride to improve sexual desire in women with breast or gynecologic cancers has completed…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer [Phase 3]
Phase 3 trial evaluating symptom benefit rate of trabectedin plus pegylated liposomal doxorubicin (PLD) in recurrent ovarian cancer was term…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Efficacy of Neoadjuvant Hyperthermic Intraperitoneal Chemotherapy in Advanced High-grade Serous Ovarian Cancer (the NHIPEC Trial) [Phase 2]
Phase 2 trial investigating neoadjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced high-grade serous ovarian cancer; sta…
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients [Phase 3]
Phase 3 ARIEL4 trial comparing rucaparib to chemotherapy in BRCA-mutant ovarian, fallopian tube, or primary peritoneal cancer has completed …
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer [Phase 3]
Phase 3 randomized trial in ovarian cancer completed; no additional details provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]
A clinical trial evaluating topotecan in combination with gefitinib (Iressa) for ovarian, peritoneal, or fallopian tube cancers has complete…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer [Phase 3]
Phase 3 clinical trial results update for OTL38 used in intra-operative imaging of folate receptor positive ovarian cancer has completed wit…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer [Phase 4]
Phase 4 clinical trial update of PARP inhibitor as oral maintenance in low-risk ovarian cancer is underway, status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy [Phase 2]
Phase 2 study results assess niraparib in combination with bevacizumab as maintenance therapy for advanced ovarian cancer after response to …
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery [Phase 2]
Phase 2 trial update on IGFBP-2 vaccine with combination chemotherapy for stage III-IV ovarian, fallopian tube, or primary peritoneal cancer…